The earnings call reflects strong financial performance with record revenue and EBITDA figures, robust growth in key segments, and strategic advancements. However, concerns surrounding regulatory changes and trial enrollment challenges present potential headwinds. Despite these challenges, the overall sentiment remains positive due to the company's strong financial position and increased guidance.

Company Guidance -

Q3 2025

During the MiMedx Second Quarter 2025 Operating and Financial Results Conference Call, the company reported a 13% year-over-year increase in net sales, reaching a record $99 million. The adjusted gross profit margin stood at 84%, while adjusted EBITDA was $24 million, accounting for 25% of net sales. The company ended the quarter with a cash balance of $119 million, an increase of $12 million from the previous quarter, and expects to end the year with more than $150 million in cash. MiMedx revised its full-year revenue growth outlook from high single digits to low double digits and anticipates a full-year adjusted EBITDA margin above 20%. The company is also preparing for Medicare reimbursement reforms set for January 1, 2026, while continuing to innovate and diversify its product portfolio, particularly in the wound care and surgical markets.

Record Quarterly Revenue and EBITDA

The company achieved the highest quarterly revenue and adjusted EBITDA in its history, with a 13% increase in net sales to $99 million and an adjusted EBITDA of $24 million, representing 25% of net sales.

Strong Performance in Wound and Surgical Franchises

Both the Wound and Surgical franchises experienced double-digit growth, with the Surgical business growing by 15% and Wound sales increasing by 12% compared to the prior year.

Cash Flow and Balance Sheet Improvements

The company generated solid cash flow, ending the quarter with a cash balance of $119 million, an increase of $12 million, and expects to end the year with over $150 million in cash.

Increased Full Year Revenue Guidance

Due to strong performance and current momentum, the company increased its full-year revenue growth outlook from high single digits to low double digits.

Strategic Initiatives and Market Expansion

The company made progress with new product launches like EPIEXRESS and collaborations with Vaporox Inc., and plans to expand its offerings in the wound care and surgical markets.

MiMedx Group (MDXG) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

MDXG Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	0.06 / -	0.05	―	―	―
Jul 30, 2025	2025 (Q2)	0.05 / 0.06	0.12	-50.00% (-0.06)	―
Apr 30, 2025	2025 (Q1)	0.05 / 0.05	0.06	-16.67% (>-0.01)	―
Feb 26, 2025	2024 (Q4)	0.07 / 0.05	0.32	-84.38% (-0.27)	―
Oct 30, 2024	2024 (Q3)	0.04 / 0.05	0.06	-16.67% (>-0.01)	―
Jul 30, 2024	2024 (Q2)	0.07 / 0.12	0	―	―
Apr 30, 2024	2024 (Q1)	0.04 / 0.06	-0.06	200.00% (+0.12)
Feb 28, 2024	2023 (Q4)	0.07 / 0.32	-0.02	1700.00% (+0.34)	―
Oct 30, 2023	2023 (Q3)	0.05 / 0.06	-0.09	166.67% (+0.15)
Aug 01, 2023	2023 (Q2)	-0.02 / 0.00	-0.11	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

MDXG Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 30, 2025	$6.52	$7.19	+10.28%
Apr 30, 2025	$6.88	$6.32	-8.14%
Feb 26, 2025	$8.01	$8.14	+1.62%
Oct 30, 2024	$5.69	$6.85	+20.39%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does MiMedx Group Inc. (MDXG) report earnings?

MiMedx Group Inc. (MDXG) is schdueled to report earning on Oct 29, 2025, Before Open (Not Confirmed).

What is MiMedx Group Inc. (MDXG) earnings time?

MiMedx Group Inc. (MDXG) earnings time is at Oct 29, 2025, Before Open (Not Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is MDXG EPS forecast?

MDXG EPS forecast for the fiscal quarter 2025 (Q3) is 0.06.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing